期刊文献+

血胆固醇水平对多发性骨髓瘤患者生存状况的影响 被引量:3

Effect of blood cholesterol levels on survival of patients with multiple myeloma
下载PDF
导出
摘要 目的探索血胆固醇水平对多发性骨髓瘤患者生存状况的影响。方法选取2014-06至2017-09医院接受治疗的136例多发性骨髓瘤患者为观察组,另选取同期82例接受体检的健康者为对照组,收集患者一般资料并进行回顾性分析。结果观察组的血清总胆固醇[(2. 67±1. 12) mmol/L]、低密度脂蛋白[(1. 62±0. 98) mmol/L]、载脂蛋白B[(0. 45±0. 28) mmol/L]及高密度脂蛋白水平[(0. 81±0. 28) mmol/L],与对照组相比,差异有统计学意义(P <0. 05)。Ⅲ期患者生存率显著低于Ⅰ期和Ⅱ期,差异有统计学意义(P <0. 05)。Ig A型多发性骨髓瘤患者的低密度脂蛋白水平[(1. 38±0. 56) mmol/L]最低,轻链型多发性骨髓瘤患者的低密度脂蛋白水平[(2. 25±0. 43) mmol/L]最高,差异有统计学意义(P <0. 05)。结论多发性骨髓瘤的疾病发展状况和生存状况与血胆固醇水平有密切关系,血胆固醇水平过低导致患者病情恶化,产生较高耐药性,从而降低生存率及生存质量。 Objective To explore the effects of blood cholesterol levels on the survival of patients with multiple myeloma.Methods One hundred and thirty-six patients with multiple myeloma who were treated in the hospital between June 2014 and September 2017 were selected as the observation group,while another eighty-two healthy physical examinees were selected as the control group.Relevant data was collected and retrospectively analyzed.Results Serum levels of total cholesterol[(2.67±1.12)mmol/L],low-density lipoprotein[(1.62±0.98)mmol/L],apolipoprotein B[(0.45±0.28)mmol/L]and high-density lipoprotein[(0.81±0.28)mmol/L]were significantly lower in the observation group than in the control group(P<0.05).The survival rate of stageⅢpatients was significantly lower than that of stageⅠand stageⅡpatients(P<0.05).Low-density lipoprotein levels[(1.38±0.56)mmol/L]were the lowest in patients with Ig A multiple myeloma,but[(2.25±0.43)mmol/L]were the highest in patients with lightchain multiple myeloma(P<0.05).Conclusions The development and survival of multiple myeloma are closely related to blood cholesterol levels that depend on the intake of low-density lipoprotein.Low blood cholesterol levels can lead to the deterioration of a patient’s condition and drug resistance,which negatively affects patients’survival and quality of life.
作者 董月华 梁艳 严怀宁 DONG Yuehua;LIANG Yan;YAN Huaining(Department of Internal Medicine,Beijing Municipal Corps Hospital of PAP,Beijing100027,China;Pharmacy,the Third Medical Center of Chinese PLA General Hospital,Beijing100039,China;Jiangsu Provincial Corps Hospital,Chinese People’s Armed Police Force,Yangzhou225003,China)
出处 《武警医学》 CAS 2019年第5期420-422,426,共4页 Medical Journal of the Chinese People's Armed Police Force
关键词 血胆固醇 多发性骨髓瘤 低密度脂蛋白 生存状况 blood cholesterol multiple myeloma low density lipoprotein survival status
  • 相关文献

参考文献10

二级参考文献35

  • 1Strasak A M, Pfeiffer R M, Bran L J, et al. Time-depen- dent association of total serum cholesterol and cancer inci- dence in a cohort of 172, 210 men and women: a prospective 19-year follow up study[J]. Ann Oncol, 2009, 20(6): 1113.
  • 2Furberg A S, Veierd M B, Wilsgaard T, et al. Serum high- density lipoprotein cholesterol, metabolic profile, and breast cancer risk[J]. J Natl Cancer Inst, 2004, 96(15): 1152.
  • 3Pui C H, Evans W E. Treatment of acute lymphoblastic leukemia[J]. N Engl J Med, 2006, 354(2): 166.
  • 4张之南,沈悌.血液病诊断及疗效标准[M].3版.北京:科学出版社,2010:65.
  • 5Phekoo K J, Schey S A, Richards M A, et al. A population study to define the incidence and survival of multiple myeloma in a National Health Service Region in UK[J]. Br J Haema- tol, 2004, 127(3): 299.
  • 6Bonville D A, Paker T S, Lvine D M, et al. The relation- ships hypocholesterolemia to cytokine concentration and mor- tality critically ill patients with systemic inflammatory re- sponse syndrome[J ]. Surg Infect (Larchrnt), 2004, 5 ( 1 ) : 39.
  • 7Jafri H, Alsheikh-Ali A A, Karas R H. Baseline and on- treatment high-density lipoprotein cholesterol and the risk of cancer in randomized controlled trials of lipid-altering therapy [J]. J Am Coil cardiol, 2010, 55(25): 2846.
  • 8Guo E Q, Chen L R, Xie Q P, et al. Serum HDL-C as a po- tential biomarker for nodal stages in gastric cancer[J]. Ann Surg Oncol, 2009, 14(9): 2528.
  • 9Desgrosellier JS,Cheresh DA. Integrins in cancer=bio- logical implications and therapeutic opportunities[J]. Nat Rev Cancer,2010,10(1) :9-22.
  • 10周细国,杨伟平,凌锋,陈琳磊,李登清.肺癌患者血清a-酸性糖蛋白和C-反应蛋白检测的临床应用价值[J].实用预防医学,2009,16(3):899-900. 被引量:1

共引文献100

同被引文献30

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部